Hepion Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Hepion Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Hepion Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $118K, a 51.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $118K -$124K -51.2% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $151K +$151K Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $182K +$182K Mar 31, 2024 10-Q 2024-05-21
Q4 2023 $213K +$162K +321% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $243K +$142K +142% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $0 -$169K -100% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $0 -$237K -100% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $50.6K -$253K -83.3% Dec 31, 2022 10-K 2024-04-16
Q3 2022 $100K -$269K -72.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $169K -$268K -61.3% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $237K -$257K -52.1% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $304K -$253K -45.4% Dec 31, 2021 10-K 2023-04-10
Q3 2021 $369K -$245K -39.9% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $436K -$236K -35.1% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $494K -$231K -31.9% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $556K -$241K -30.3% Dec 31, 2020 10-K 2022-04-08
Q3 2020 $614K -$28.2K -4.39% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $673K -$10.9K -1.59% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $725K +$777 +0.11% Mar 31, 2020 10-Q 2020-06-30
Q4 2019 $798K Dec 31, 2019 10-K 2021-03-31
Q3 2019 $642K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $684K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $724K Mar 31, 2019 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.